Lymphatic Filariasis in Oceania

[1]  Thomas R Burkot,et al.  Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village , 2015, Parasites & Vectors.

[2]  D. Musso,et al.  Filariasis serosurvey, New Caledonia, South Pacific, 2013 , 2015, Parasites & Vectors.

[3]  P. Zimmerman,et al.  Molecular epidemiology, phylogeny and evolution of the filarial nematode Wuchereria bancrofti. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  K. Ramaiah,et al.  Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease , 2014, PLoS neglected tropical diseases.

[5]  R. S. Soares Magalhaes,et al.  Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration , 2014, PLoS neglected tropical diseases.

[6]  S. Hay,et al.  The global distribution and transmission limits of lymphatic filariasis: past and present , 2014, Parasites & Vectors.

[7]  Steven A. Williams,et al.  Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa , 2014, PLoS neglected tropical diseases.

[8]  D. Addiss,et al.  Pilot Assessment of Soil-Transmitted Helminthiasis in the Context of Transmission Assessment Surveys for Lymphatic Filariasis in Benin and Tonga , 2014, PLoS neglected tropical diseases.

[9]  W. Melrose,et al.  Evaluation of the Og34C filter paper technique in lymphatic filariasis prevalence studies. , 2014, Lymphology.

[10]  R. Rao,et al.  Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation , 2013, PLoS neglected tropical diseases.

[11]  H. Bossin,et al.  Population Studies of the Filarial Vector Aedes polynesiensis (Diptera: Culicidae) in Two Island Settings of French Polynesia , 2013, Journal of medical entomology.

[12]  Edward K. Thomsen,et al.  Mosquito-Parasite Interactions Can Shape Filariasis Transmission Dynamics and Impact Elimination Programs , 2013, PLoS neglected tropical diseases.

[13]  H. Dagoro,et al.  Insecticidal bed nets and filariasis transmission in Papua New Guinea. , 2013, The New England journal of medicine.

[14]  D. MacLaren,et al.  A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands , 2013, Parasites & Vectors.

[15]  P. Siba,et al.  Population Genetics of the Filarial Worm Wuchereria bancrofti in a Post-treatment Region of Papua New Guinea: Insights into Diversity and Life History , 2013, PLoS neglected tropical diseases.

[16]  Samantha N. McNulty,et al.  Inter and intra-specific diversity of parasites that cause lymphatic filariasis. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  J. McCarthy,et al.  Neglected Tropical Diseases of Oceania: Review of Their Prevalence, Distribution, and Opportunities for Control , 2013, PLoS neglected tropical diseases.

[18]  P. Graves,et al.  Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011 , 2013, Parasites & Vectors.

[19]  D. Musso,et al.  Predictive value of the eosinophil counts in the biological diagnosis of lymphatic filariasis in French Polynesia. , 2012, Medecine et maladies infectieuses.

[20]  T. Nutman,et al.  Antibody to the Filarial Antigen Wb123 Reflects Reduced Transmission and Decreased Exposure in Children Born following Single Mass Drug Administration (MDA) , 2012, PLoS neglected tropical diseases.

[21]  Steven A. Williams,et al.  A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis , 2012, PLoS neglected tropical diseases.

[22]  P. Lammie,et al.  Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa , 2011, Annals of tropical medicine and parasitology.

[23]  T. Naseri,et al.  Application of the Filariasis CELISA Antifilarial IgG4 Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific , 2011, Journal of tropical medicine.

[24]  Shannon K. McClintock,et al.  First evidence of spatial clustering of lymphatic filariasis in an Aedes polynesiensis endemic area. , 2011, Acta tropica.

[25]  Q. Bassat,et al.  The Impact of a Filariasis Control Program on Lihir Island, Papua New Guinea , 2011, PLoS neglected tropical diseases.

[26]  M. Alpers,et al.  Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea , 2011, PLoS neglected tropical diseases.

[27]  N. Bhullar,et al.  Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia , 2010, Parasites & Vectors.

[28]  J. Kazura,et al.  Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections. , 2010, The American journal of tropical medicine and hygiene.

[29]  M. Bangs,et al.  Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[30]  H. Joseph,et al.  Applicability of the Filter Paper Technique for Detection of Antifilarial IgG4 Antibodies Using the Bm14 Filariasis CELISA , 2010, Journal of parasitology research.

[31]  P. Hotez,et al.  Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific region. , 2010, Advances in parasitology.

[32]  Steven A. Williams,et al.  Heritable factors play a major role in determining host responses to Wuchereria bancrofti infection in an isolated South Pacific island population. , 2009, The Journal of infectious diseases.

[33]  P. Kelly,et al.  Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries , 2009, BMC infectious diseases.

[34]  Shannon K. McClintock,et al.  Xenomonitoring of Wuchereria bancrofti and Dirofilaria immitis infections in mosquitoes from American Samoa: trapping considerations and a comparison of polymerase chain reaction assays with dissection. , 2009, The American journal of tropical medicine and hygiene.

[35]  T. Burkot,et al.  Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa. , 2009, The American journal of tropical medicine and hygiene.

[36]  R. Rao,et al.  A qPCR-based multiplex assay for the detection of Wuchereria bancrofti, Plasmodium falciparum and Plasmodium vivax DNA. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  Steven A. Williams,et al.  The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea , 2008, PLoS neglected tropical diseases.

[38]  S. Chanteau,et al.  [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?]. , 2008, Bulletin de la Societe de pathologie exotique.

[39]  T. Handzel,et al.  Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa. , 2008, The American journal of tropical medicine and hygiene.

[40]  M. Alpers,et al.  Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. , 2008, The American journal of tropical medicine and hygiene.

[41]  P. Graves,et al.  Wuchereria bancrofti Filariasis Control in Samoa before PacELF (Pacific Programme to Eliminate Lymphatic Filariasis) , 2007 .

[42]  M. Alpers,et al.  Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. , 2007, The American journal of tropical medicine and hygiene.

[43]  毅 栗原.  World Health Organization Western Pacific Region(編著),The PacELF Way towards the elimination of lymphatic filariasis from the Pacific 1999-2005, Prepared by PacELF, 2006, A4, 239頁 , 2006 .

[44]  E. Michael,et al.  Transmission dynamics of lymphatic filariasis: vector‐specific density dependence in the development of Wuchereria bancrofti infective larvae in mosquitoes , 2006, Medical and veterinary entomology.

[45]  A. Legrand,et al.  PCR and dissection as tools to monitor filarial infection of Aedes polynesiensis mosquitoes in French Polynesia , 2006, Filaria journal.

[46]  R. Russell,et al.  Aedes aegypti (L.) and Aedes polynesiensis Marks (Diptera: Culicidae) in Moorea, French Polynesia: A Study of Adult Population Structures and Pathogen (Wuchereria bancrofti and Dirofilaria immitis) Infection Rates to Indicate Regional and Seasonal Epidemiological Risk for Dengue and Filariasis , 2005, Journal of medical entomology.

[47]  G. Taleo,et al.  Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach. , 2005, The American journal of tropical medicine and hygiene.

[48]  F. F. Hunter,et al.  Attraction of Culex pipiens/restuans (Diptera: Culicidae) Mosquitoes to Bird Uropygial Gland Odors at Two Elevations in the Niagara Region of Ontario , 2005, Journal of medical entomology.

[49]  J. Roux,et al.  [The history of lymphatic filarlasis control programme in French Polynesia: lessons from a 50 years effort]. , 2005, Bulletin de la Societe de pathologie exotique.

[50]  S. D. de Vlas,et al.  Assessing density dependence in the transmission of lymphatic filariasis: uptake and development of Wuchereria bancrofti microfilariae in the vector mosquitoes , 2004, Medical and veterinary entomology.

[51]  J. Kazura,et al.  Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis , 2003, Genes and Immunity.

[52]  R. Speare,et al.  Certifying lymphatic filariasis elimination in the Pacific--the need for new tools. , 2003, Pacific Health Dialog.

[53]  J. Kazura,et al.  Sensitivity and specificity of ultrasound detection and risk factors for filarial-associated hydroceles. , 2003, The American journal of tropical medicine and hygiene.

[54]  M. Alpers,et al.  Mass treatment to eliminate filariasis in Papua New Guinea. , 2002, The New England journal of medicine.

[55]  E. Michael,et al.  Transmission dynamics of lymphatic filariasis: density‐dependence in the uptake of Wuchereria bancrofti microfilariae by vector mosquitoes , 2002, Medical and veterinary entomology.

[56]  G. Pichon.  Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. , 2002, Annals of tropical medicine and parasitology.

[57]  T. Burkot,et al.  Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. , 2002, Annals of tropical medicine and parasitology.

[58]  J. Kazura,et al.  Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea , 2002, Medical and veterinary entomology.

[59]  T. Burkot,et al.  The PacELF programme: will mass drug administration be enough? , 2002, Trends in parasitology.

[60]  T. Nutman,et al.  Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. , 2001, The American journal of tropical medicine and hygiene.

[61]  M. Alpers,et al.  Ecologic and biologic determinants of filarial antigenemia in bancroftian filariasis in Papua New Guinea. , 2001, The Journal of infectious diseases.

[62]  M. Alpers,et al.  Transmission Intensity Determines Lymphocyte Responsiveness and Cytokine Bias in Human Lymphatic Filariasis1 , 2001, The Journal of Immunology.

[63]  M. Alpers,et al.  Migration and dispersal of lymphatic filariasis in Papua New Guinea. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[64]  N. L. Nguyen,et al.  The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort , 2001, Tropical medicine & international health : TM & IH.

[65]  R. Speare,et al.  Prevalence of filarial antigenaemia in Papua Nnew Guinea: results of surveys by the School of Public Health and Tropical Medicine, James Cook University, Townsville, Australia. , 2000, Papua and New Guinea medical journal.

[66]  M. Alpers,et al.  Control of lymphatic filariasis in a hunter-gatherer group in Madang Province. , 2000, Papua and New Guinea medical journal.

[67]  N. Alexander.  Wuchereria bancrofti infection and disease in a rural area of Papua New Guinea. , 2000, Papua and New Guinea medical journal.

[68]  W. Melrose,et al.  Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole. , 2000, Papua and New Guinea medical journal.

[69]  M. Alpers,et al.  Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province. , 2000, Papua and New Guinea medical journal.

[70]  M. Alpers,et al.  The epidemiology and control of lymphatic filariasis on Lihir Island, New Ireland Province. , 2000, Papua and New Guinea medical journal.

[71]  M. Alpers,et al.  Application of a polymerase chain reaction-ELISA to detect Wuchereria bancrofti in pools of wild-caught Anopheles punctulatus in a filariasis control area in Papua New Guinea. , 2000, The American journal of tropical medicine and hygiene.

[72]  P. Sapak,et al.  Efficacy of mass single-dose diethylcarbamazine and DEC-fortified salt against bancroftian filariasis in Papua New Guinea six months after treatment. , 2000, Papua and New Guinea medical journal.

[73]  N. L. Nguyen,et al.  Assessment of immunochromatographic test for rapid lymphatic filariasis diagnosis. , 1999, Parasite.

[74]  M. Alpers,et al.  Acute disease episodes in a Wuchereria bancrofti-endemic area of Papua New Guinea. , 1999, The American journal of tropical medicine and hygiene.

[75]  X. Deparis,et al.  Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status. , 1999, Parasite immunology.

[76]  B. Gentile,et al.  [Survey of lymphatic filariasis on Ouvea Island in New Caledonia]. , 1999, Medecine tropicale : revue du Corps de sante colonial.

[77]  M. Alpers,et al.  Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes , 1998, The Lancet.

[78]  M. Shimada,et al.  Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji. , 1998, Bulletin of the World Health Organization.

[79]  L. Nicolas,et al.  Multiplex polymerase chain reaction for detection of Dirofilaria immitis (Filariidea: Onchocercidae) and Wuchereria bancrofti (Filarioidea: Dipetalonematidae) in their common vector Aedes polynesiensis (Diptera: Culicidae). , 1997, Journal of medical entomology.

[80]  L. Nicolas.  New tools for diagnosis and monitoring of bancroftian filariasis parasitism: the Polynesian experience. , 1997, Parasitology today.

[81]  M. Alpers,et al.  Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. , 1997, Journal of Infectious Diseases.

[82]  L. Nicolas,et al.  Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. , 1997, The Journal of infectious diseases.

[83]  N. L. Nguyen,et al.  Control of bancroftian filariasis in an endemic area of Polynesia by ivermectin 400 μg/kg , 1996 .

[84]  M. Alpers,et al.  Transmission dynamics of Wuchereria bancrofti in East Sepik Province, Papua New Guinea. , 1996, The American journal of tropical medicine and hygiene.

[85]  B. Grenfell,et al.  Re-assessing the global prevalence and distribution of lymphatic filariasis , 1996, Parasitology.

[86]  L. Nicolas,et al.  Advantages of an annual single dose of ivermectin 400 μg/kg plus diethylcarbamazine for community treatment of bancroftian filariasis , 1995 .

[87]  F. Lardeux,et al.  Wuchereria bancrofti (Filariidea: Dipetalonematidae) and its vector Aedes polynesiensis (Diptera: Culicidae) in a French Polynesian village. , 1995, Journal of medical entomology.

[88]  S. Chanteau,et al.  Wuchereria bancrofti filariasis in French Polynesia: age-specific patterns of microfilaremia, circulating antigen, and specific IgG and IgG4 responses according to transmission level. , 1995, International journal for parasitology.

[89]  M. Sasa.  Human filariasis: A global survey of epidemiology and control , 1976 .